Ozempic Linked With Lower Risk of Alzheimer's Diagnosis
Med Page Today
OCTOBER 24, 2024
(MedPage Today) -- Semaglutide (Ozempic) was tied to a reduced risk of Alzheimer's disease diagnoses in people with type 2 diabetes, observational data showed. In emulation target trials involving more than 1 million eligible diabetes patients.
Let's personalize your content